drugset / Trial / NCT05199597

The Response to Atropine Drops (RAD) Study

NCT05199597

Phase 0 Completed 30 enrolled Ohio State University
NaSequentialOpen-labelOther

Summary

The purpose of this study is to examine the comfort of giving low concentration atropine eye drops.

Timeline

Start
2022-05-19
Primary completion
2022-06-15
Completion
2022-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 0.01 % Topical
Subject Atropine Other / unclassified 0.05 % Topical

Indications